J-Pharma Co (TSE:520A) Other Stockholders Equity: 円389.63 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:520A J-Pharma Co Ltd TSE:520A
9 GF Score
Price 円290.00
View Full Analysis

What is J-Pharma Co Other Stockholders Equity?

J-Pharma Co TSE:520A -2.36% 9 Other Stockholders Equity is 円389.63 Mil as of Dec. 2025. GuruFocus rates TSE:520A with a GF Score™ of 9/100.

J-Pharma Co's Other Stockholders Equity for the quarter that ended in Dec. 2025 was 円389.63 Mil.

J-Pharma Co's quarterly Other Stockholders Equity declined from Mar. 2024 (円1,769.64 Mil) to Mar. 2025 (円1,072.40 Mil) and declined from Mar. 2025 (円1,072.40 Mil) to Dec. 2025 (円389.63 Mil).

J-Pharma Co's annual Other Stockholders Equity increased from . 20 (円0.00 Mil) to Mar. 2024 (円1,769.64 Mil) but then declined from Mar. 2024 (円1,769.64 Mil) to Mar. 2025 (円1,072.40 Mil).

J-Pharma Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for J-Pharma Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J-Pharma Co Other Stockholders Equity Chart

J-Pharma Co Annual Data
Trend Mar24 Mar25
Other Stockholders Equity
1,769.64 1,072.40

J-Pharma Co Quarterly Data
Mar24 Mar25 Dec25
Other Stockholders Equity 1,769.64 1,072.40 389.63
TSE:520A
9GF Score
J-Pharma Co Ltd TSE:520A
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

J-Pharma Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of 円389.63 Mil mean?
J-Pharma Co (TSE:520A) has a Other Stockholders Equity of 円389.63 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on J-Pharma Co and its competitors.
Is J-Pharma Co's Other Stockholders Equity too high?
J-Pharma Co's current Other Stockholders Equity is 円389.63 Mil. Overall, J-Pharma Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does J-Pharma Co's Other Stockholders Equity compare to VRTX and REGN?
J-Pharma Co's Other Stockholders Equity of 円389.63 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on J-Pharma Co and its competitors. J-Pharma Co's current Other Stockholders Equity is 円389.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J-Pharma Co stock overvalued right now?
J-Pharma Co (TSE:520A) has a current Other Stockholders Equity of 円389.63 Mil. The current Other Stockholders Equity is 円389.63 Mil. J-Pharma Co's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For J-Pharma Co (TSE:520A), the current Other Stockholders Equity is 円389.63 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

J-Pharma Co Business Description

Address 1-10-11, HamamatsuCho, 8th floor, Minato-Ku, Tokyo, JPN, 105-0013
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
9GF Score

Get the complete analysis for TSE:520A

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円290.00
Price